mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

The successful development of several coronavirus disease 2019 (COVID-19) vaccines has substantially reduced morbidity and mortality in regions of the world where the vaccines have been deployed. However, in the wake of the emergence of viral variants that are able to evade vaccine-induced neutraliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplonek, Paulina, Cizmeci, Deniz, Fischinger, Stephanie, Collier, Ai-ris, Suscovich, Todd, Linde, Caitlyn, Broge, Thomas, Mann, Colin, Amanat, Fatima, Dayal, Diana, Rhee, Justin, de St. Aubin, Michael, Nilles, Eric J., Musk, Elon R., Menon, Anil S., Saphire, Erica Ollmann, Krammer, Florian, Lauffenburger, Douglas A., Barouch, Dan H., Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995030/
https://www.ncbi.nlm.nih.gov/pubmed/35348368
http://dx.doi.org/10.1126/scitranslmed.abm2311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995030/
https://www.ncbi.nlm.nih.gov/pubmed/35348368
http://dx.doi.org/10.1126/scitranslmed.abm2311

Ejemplares similares